Remarkably, targeted silencing of CHAF1B enhances transcription of IFNα-stimulated genes and promotes IFNα-dependent antineoplastic responses in primary MPN progenitor cells. This evidence concerns the gene CHAF1B and myeloproliferative neoplasm.